Full Name | C J Jos |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 21 Municipal Dr, Arnold, Missouri |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154386746 | NPI | - | NPPES |
201893823 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0800X | Psychiatry & Neurology - Psychiatry | R8157 (Missouri) | Primary |
Entity Name | Community Treatment Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598781189 PECOS PAC ID: 0749171585 Enrollment ID: O20040325000428 |
News Archive
The largest genetics study to date of type 2 diabetes (T2D) has identified new gene variants associated with risk for the common metabolic disease. An international scientific consortium, studying multiethnic populations, uncovered genes that may point to biological targets for developing more effective drugs for T2D.
An innovative new study is set to examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.
Loyola University Medical Center has received the American Heart Association's Mission: Lifeline Silver Receiving Quality Achievement Award, which recognizes Loyola's commitment and success in implementing an exceptional standard of care for heart attack patients.
Painstaking new analysis of the genetic sequence of the X chromosome—long perceived as the "female" counterpart to the male-associated Y chromosome—reveals that large portions of the X have evolved to play a specialized role in sperm production.
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the completion of an agreement with the Joslin Diabetes Center to exclusively license intellectual property covering bone morphogenetic protein 7 (BMP7), which has been shown to play a role in the regulation of brown fat development.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
C J Jos, MD 227 E Main St, Festus, MO 63028-1952 Ph: (636) 931-2700 | C J Jos, MD 21 Municipal Dr, Arnold, MO 63010-1012 Ph: (636) 296-6206 |
News Archive
The largest genetics study to date of type 2 diabetes (T2D) has identified new gene variants associated with risk for the common metabolic disease. An international scientific consortium, studying multiethnic populations, uncovered genes that may point to biological targets for developing more effective drugs for T2D.
An innovative new study is set to examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.
Loyola University Medical Center has received the American Heart Association's Mission: Lifeline Silver Receiving Quality Achievement Award, which recognizes Loyola's commitment and success in implementing an exceptional standard of care for heart attack patients.
Painstaking new analysis of the genetic sequence of the X chromosome—long perceived as the "female" counterpart to the male-associated Y chromosome—reveals that large portions of the X have evolved to play a specialized role in sperm production.
Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the completion of an agreement with the Joslin Diabetes Center to exclusively license intellectual property covering bone morphogenetic protein 7 (BMP7), which has been shown to play a role in the regulation of brown fat development.
› Verified 4 days ago
Ashley Harvin, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 21 Municipal Dr, Arnold, MO 63010 Phone: 636-296-6206 |